Sharyar Baradaran insider trades: Nurx Pharmaceuticals (NUXP) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Sharyar reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 13, 2009 | NUXP | ↑ Buy | 200,000 | $0.25 | $50K | By Baradaran Revocable Trust | Nov 4, 2009 (22d) |
| Mar 10, 2008 | NURX | ↑ Buy | 95,000 | $0.55 | $52K | By Baradaran Revocable Trust | Mar 28, 2008 (18d) |
| Jan 24, 2007 | INWK | ↓ Sell | 47,318 | $13.50 | $639K | Indirect | Jan 25, 2007 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Sharyar Baradaran's insider trades
Sharyar Baradaran is a director at Nurx Pharmaceuticals (NUXP). Since Jan 24, 2007, Sharyar has reported 2 open-market purchases worth $102K and 1 sale worth $639K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (5 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NUXP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.